Latest news, press releases, and SEC filings for PepGen Inc (PEPG) https://caymanjournal.com/stock/PEPG en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 01:20:38 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a press release filed as an 8-K with the SEC. PepGen is sharing early, but important, clinical trial results for their lead drug candidate. Think of it as a public progress report for investors and the medical community. The headline is: their lowest dose appears s https://caymanjournal.com/stock/PEPG/sec-filing/0001193125-26-131786 https://caymanjournal.com/stock/PEPG/sec-filing/0001193125-26-131786 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing